Chronic or Episodic Migraine (Migraine without aura, migraine with aura, or chronic migraine) research hub

A Phase 3, Multicenter, Open-Label 156-Week Extension Study To Evaluate The Long-Term Safety And Tolerability Of Oral Atogepant For The Prevention Of Migraine In Participants With Chronic Or Episodic Migraine

This study looks at the long-term safety of a new medicine called atogepant for preventing migraine headaches. It's for people who get migraines often, either regularly or sometimes, and they will take the medicine for up to three years to see how well they tolerate it.